Upgrade to SI Premium - Free Trial

InspireMD (NSPR)

0.85 +0.01 (1.19%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 4, 2026 4:01 PM - StreetInsider InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference September 3, 2026 8:00 AM - StreetInsider InspireMD (NSPR) Tops Q2 EPS by 1c August 17, 2026 7:55 AM - StreetInsider Form 8-K InspireMD, Inc. For: Aug 17 August 17, 2026 7:05 AM - SEC Filing InspireMD Reports Second Quarter 2026 Financial Results August 17, 2026 7:00 AM - StreetInsider Form 10-Q InspireMD, Inc. For: Jun 30 August 14, 2026 4:34 PM - SEC Filing InspireMD to Announce Second Quarter 2026 Financial Results August 10, 2026 4:01 PM - StreetInsider InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 7, 2026 4:01 PM - StreetInsider InspireMD names Kathleen Kennedy as SVP of global sales and marketing July 30, 2026 4:01 PM - StreetInsider InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing July 30, 2026 4:01 PM - StreetInsider Form 8-K InspireMD, Inc. For: Jul 23 July 29, 2026 5:01 PM - SEC Filing Form 8-K InspireMD, Inc. For: Jul 17 July 23, 2026 5:00 PM - SEC Filing Form 8-K InspireMD, Inc. For: Jun 26 July 2, 2026 5:01 PM - SEC Filing InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 12, 2026 4:05 PM - StreetInsider Form 8-K InspireMD, Inc. For: Jun 11 June 11, 2026 8:06 AM - SEC Filing InspireMD reports 30-day trial results for carotid stent system June 11, 2026 8:03 AM - StreetInsider InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures June 11, 2026 8:00 AM - StreetInsider InspireMD enrolls first patient in pivotal neuro protection study June 8, 2026 8:02 AM - StreetInsider InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures June 8, 2026 8:00 AM - StreetInsider Full Article List